The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Seminar Title
Seminar M6 – Patient safety and compounding technologies
Affiliation
Apotheek A15 (A15 Pharmacy)
Country
The Netherlands
1. Current Status, Position
- Hospital pharmacist – Head of Pharmacy ‘Apotheek A15’ (A15 Pharmacy);
- Board Member – Dutch Association of Hospital Pharmacists.
2. Education
András Vermes (PharmD, PhD) received his Pharmacy education at the University Utrecht (Utrecht, The Netherlands; 1994-2000) and performed his PhD research at the Academic Medical Centre (Amsterdam, The Netherlands; 2000). His post academic hospital pharmacy residency was performed at the Erasmus Medical Center (Rotterdam; The Netherlands; 2000-2004). Dr. Vermes has been the Head of the department of Drug Manufacturing and Compounding of the hospital pharmacy of the Erasmus Medical Centre since 2005. He has been a Board Member of the Dutch Association of Hospital Pharmacists since November 2011. Since June 2013 he is Head of Pharmacy of Apotheek A15 (A15 Pharmacy), a GMP licensed drug manufacturing hospital pharmacy in the center of the Netherlands (Gorinchem, The Netherlands).
3. Research Area
The main areas of expertise of Dr. Vermes are drug manufacturing, compounding, quality control and quality assurance.
Conflict of interest: None